Cti biopharma board
WebSEATTLE, Feb. 7, 2024 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that an authorized subcommittee of the Compensation Committee of its Board of Directors granted equity awards to three new employees as equity inducement awards outside of the Company's Amended and Restated 2024 Equity Incentive Plan (but under … WebOct 3, 2016 · SEATTLE, Oct. 3, 2016 /PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA:CTIC) today announced that James A. Bianco, M.D, CTI BioPharma's President and Chief Executive Officer, has retired from the Company effective on October 2 nd.At the request of the Board of Directors, Richard Love, a director of CTI …
Cti biopharma board
Did you know?
WebNumbers reported do not include change in pension value and non-qualified deferred compensation earnings. Board of Directors in CTI BIOPHARMA CORP For its 2024 fiscal year, CTI BIOPHARMA CORP, listed the following board members on its annual proxy statement to the SEC. Browse Board of Directors By First Name A B C D E F G H I J K … WebSEATTLE , Jan. 24, 2024 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that an authorized subcommittee of the Compensation Committee of its Board of Directors granted an equity award to a new employee as an equity inducement award outside of the Company's Amended and Restated Jan 05, 2024
WebJan 13, 2016 · SEATTLE, Jan. 13, 2016 /PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced that Matthew Perry, President of BVF Partners L.P. (BVF Partners) and CTI... Web1 day ago · SEATTLE, Wash., April 12, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today announced that the management team will participate in two upcoming investor …
WebFeb 8, 2024 · SEATTLE, Feb. 7, 2024 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that an authorized subcommittee of the Compensation Committee of its Board of Directors granted equity... WebMar 6, 2024 · SEATTLE, March 6, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today announced that an authorized subcommittee of the Compensation Committee of its Board of …
WebCompany profile page for CTI BioPharma Corp including stock price, company news, press releases, executives, board members, and contact information
WebApr 10, 2024 · SEATTLE , April 10, 2024 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today announced that an authorized subcommittee of the Compensation Committee of its Board of … great falls community bandWeb1 day ago · CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today announced ... flip throughWebNov 15, 2024 · T +1 206-282-7100 T +1 800-215-2355 (US only) F +1 206-284-6206 flip through path vlsiWebMay 13, 2024 · CTI BioPharma and biotech stocks across the board have been having a hard time getting investors' attention recently. As a result, it looks like a bargain right now. Even after Friday's big... great falls college tuitionWebCTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. … great falls community choirWebAug 24, 2024 · Biopharma Commercial Leader Brings Significant Expertise Launching Novel Oncology Therapies. SEATTLE, Aug. 24, 2024 /PRNewswire/ -- CTI BioPharma … great falls community calendarWebMar 30, 2024 · CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related cancers, today announced that an authorized subcommittee of the Compensation Committee of its Board of Directors granted equity awards to four new … great falls commercial lease